Renaissance Technologies's AMGN Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 167.2K shares of Amgen Inc. (AMGN) worth $47.2 M, representing 0.06% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2022, adding 1.1M shares. Largest reduction occurred in Q2 2020, reducing 2.1M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +1.27 M | Add 0.00% | 1.27 M | $98.66 |
| Q3 2013 | -1.2 M | Reduce 94.43% | 71,000 | $111.93 |
| Q4 2013 | +791,245 | Add 1114.43% | 862,245 | $114.08 |
| Q1 2014 | -528,896 | Reduce 61.34% | 333,349 | $123.34 |
| Q2 2014 | -22,704 | Reduce 6.81% | 310,645 | $118.37 |
| Q3 2014 | -42,200 | Reduce 13.58% | 268,445 | $140.46 |
| Q4 2014 | +202,000 | Add 75.25% | 470,445 | $159.29 |
| Q1 2015 | +1.05 M | Add 223.96% | 1.52 M | $159.85 |
| Q2 2015 | +246,200 | Add 16.15% | 1.77 M | $153.52 |
| Q3 2015 | -205,900 | Reduce 11.63% | 1.56 M | $138.32 |
| Q4 2015 | -1.42 M | Reduce 90.64% | 146,500 | $162.33 |
| Q1 2016 | +334,700 | Add 228.46% | 481,200 | $149.93 |
| Q2 2016 | +695,245 | Add 144.48% | 1.18 M | $152.15 |
| Q3 2016 | +719,896 | Add 61.19% | 1.9 M | $166.81 |
| Q4 2016 | -117,696 | Reduce 6.21% | 1.78 M | $146.21 |
| Q1 2017 | +634,800 | Add 35.69% | 2.41 M | $164.07 |
| Q2 2017 | +986,700 | Add 40.88% | 3.4 M | $172.23 |
| Q3 2017 | +517,555 | Add 15.22% | 3.92 M | $186.45 |
| Q4 2017 | +661,745 | Add 16.89% | 4.58 M | $173.90 |
| Q1 2018 | -654,145 | Reduce 14.28% | 3.93 M | $170.48 |
| Q2 2018 | -121,700 | Reduce 3.10% | 3.8 M | $184.59 |
| Q3 2018 | +311,545 | Add 8.19% | 4.12 M | $207.29 |
| Q4 2018 | -536,545 | Reduce 13.04% | 3.58 M | $194.67 |
| Q1 2019 | -70,017 | Reduce 1.96% | 3.51 M | $189.98 |
| Q2 2019 | -545,345 | Reduce 15.54% | 2.96 M | $184.28 |
| Q3 2019 | +694,848 | Add 23.45% | 3.66 M | $193.51 |
| Q4 2019 | -498,548 | Reduce 13.63% | 3.16 M | $241.07 |
| Q1 2020 | +590,465 | Add 18.69% | 3.75 M | $202.73 |
| Q2 2020 | -2.14 M | Reduce 57.02% | 1.61 M | $235.86 |
| Q3 2020 | -1.04 M | Reduce 64.43% | 573,284 | $254.16 |
| Q4 2020 | -405,639 | Reduce 70.76% | 167,645 | $229.92 |
| Q1 2021 | -166,445 | Reduce 99.28% | 1,200 | $249.17 |
| Q2 2021 | -1,200 | Sold Out | 1,200 | $0.00 |
| Q3 2021 | +151,845 | New Buy | 151,845 | $212.65 |
| Q4 2021 | +950,008 | Add 625.64% | 1.1 M | $224.97 |
| Q1 2022 | -722,308 | Reduce 65.55% | 379,545 | $241.82 |
| Q2 2022 | +1.06 M | Add 279.33% | 1.44 M | $243.30 |
| Q3 2022 | -806,500 | Reduce 56.02% | 633,245 | $225.40 |
| Q4 2022 | +974,000 | Add 153.81% | 1.61 M | $0.26 |
| Q1 2023 | -484,600 | Reduce 30.15% | 1.12 M | $0.24 |
| Q2 2023 | -861,300 | Reduce 76.72% | 261,345 | $0.22 |
| Q3 2023 | -197,045 | Reduce 75.40% | 64,300 | $268.76 |
| Q4 2023 | +12,200 | Add 18.97% | 76,500 | $288.03 |
| Q1 2024 | -21,300 | Reduce 27.84% | 55,200 | $284.31 |
| Q2 2024 | -2,955 | Reduce 5.35% | 52,245 | $312.45 |
| Q3 2024 | -52,245 | Sold Out | 52,245 | $0.00 |
| Q4 2024 | +69,045 | New Buy | 69,045 | $260.64 |
| Q1 2025 | +45,355 | Add 65.69% | 114,400 | $311.55 |
| Q2 2025 | +162,900 | Add 142.40% | 277,300 | $279.21 |
| Q3 2025 | -110,055 | Reduce 39.69% | 167,245 | $282.20 |
Renaissance Technologies's Amgen Investment FAQs
Renaissance Technologies first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 1,274,945 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Amgen Inc. (AMGN) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Amgen Inc. (AMGN) was in Q2 2013, adding 1,274,945 shares worth $125.79 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 167,245 shares of Amgen Inc. (AMGN), valued at approximately $47.2 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Amgen Inc. (AMGN) represents approximately 0.06% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Amgen Inc. (AMGN) was 4,579,445 shares, as reported at the end of Q4 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.